Twin Tree Management’s Charles River Laboratories CRL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-1,485
Closed -$232K 1462
2025
Q3
$232K Buy
+1,485
New +$236K ﹤0.01% 1334
2024
Q3
Sell
-545
Closed -$113K 1556
2024
Q2
$113K Buy
+545
New +$123K ﹤0.01% 1175
2022
Q3
Sell
-7,060
Closed -$1.52M 1376
2022
Q2
$1.51M Sell
7,060
-19,130
-73% -$4.67M ﹤0.01% 1137
2022
Q1
$7.44M Buy
+26,190
New +$8.08M 0.01% 790
2021
Q4
Sell
-9,033
Closed -$3.51M 1616
2021
Q3
$3.73M Buy
+9,033
New +$3.75M 0.01% 875
2021
Q2
Sell
-521
Closed -$151K 1384
2021
Q1
$151K Buy
521
+503
+2,794% +$140K ﹤0.01% 1157
2020
Q4
$4K Sell
18
-428
-96% -$102K ﹤0.01% 1231
2020
Q3
$101K Sell
446
-14,039
-97% -$2.91M ﹤0.01% 1068
2020
Q2
$2.52M Sell
14,485
-1,530
-10% -$244K 0.01% 825
2020
Q1
$2.02M Buy
16,015
+14,041
+711% +$2.11M 0.01% 713
2019
Q4
$302K Sell
1,974
-3,227
-62% -$447K ﹤0.01% 991
2019
Q3
$688K Sell
5,201
-10,059
-66% -$1.35M ﹤0.01% 877
2019
Q2
$2.17M Sell
15,260
-7,512
-33% -$1.02M 0.01% 642
2019
Q1
$3.31M Buy
22,772
+14,260
+168% +$1.87M 0.02% 547
2018
Q4
$963K Buy
+8,512
New +$1.07M 0.01% 861
2018
Q3
Sell
-4,526
Closed -$508K 1085
2018
Q2
$508K Buy
+4,526
New +$489K ﹤0.01% 895

Other funds holding CRL

Twin Tree Management's CRL Position: Q4 2025 in Review

Twin Tree Management sold out of Charles River Laboratories (CRL) in Q4 2025, closing a stake of 1,485 shares — an estimated $232K sold.

Twin Tree Management first reported a position in CRL in Q2 2018 and held it in 16 quarters. The position peaked at $7.44M in Q1 2022. 582 funds tracked by Wall St. Rank hold CRL as of Q4 2025.

  • Twin Tree Management reported no remaining Charles River Laboratories position as of Q4 2025 after selling out during the quarter.
  • Twin Tree Management sold 1,485 Charles River Laboratories shares in Q4 2025, an estimated $232K.
  • Twin Tree Management first reported a position in Charles River Laboratories in Q2 2018 and held it in 16 quarters.
  • Twin Tree Management's Charles River Laboratories position peaked at $7.44M in Q1 2022.
  • 582 funds tracked by Wall St. Rank held Charles River Laboratories as of Q4 2025.

Based on Twin Tree Management's 13F filing for Q4 2025, filed 11 Feb 2026.